WG
ROIV icon

Winton Group’s Roivant Sciences ROIV Stock Holding History

Winton Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Sell
43,031
-17,426
-29% -$515K 0.05% 378
2026
Q1 		$1.67M Sell
60,457
-265,905
-81% -$6.83M 0.06% 363
2025
Q4 		$7.08M Sell
326,362
-216,971
-40% -$4.28M 0.24% 106
2025
Q3 		$8.22M Buy
543,333
+335,269
+161% +$4.15M 0.31% 80
2025
Q2 		$2.34M Buy
208,064
+106,072
+104% +$1.15M 0.12% 225
2025
Q1 		$1.03M Buy
101,992
+9,466
+10% +$102K 0.06% 401
2024
Q4 		$1.09M Buy
92,526
+1,332
+1% +$15.7K 0.07% 284
2024
Q3 		$1.05M Buy
91,194
+5,897
+7% +$67.1K 0.07% 291
2024
Q2 		$902K Buy
+85,297
New +$935K 0.06% 320

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Winton Group's ROIV Position: Q2 2026 in Review

Winton Group reduced its Roivant Sciences (ROIV) stake by 29% in Q2 2026, selling an estimated $515K and leaving 43,031 shares worth $1.52M. The position accounts for 0.05% of the portfolio, ranked #378.

Winton Group first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.22M in Q3 2025. 496 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Winton Group held 43,031 shares of Roivant Sciences worth $1.52M as of Q2 2026.
  • Winton Group sold 17,426 Roivant Sciences shares in Q2 2026, an estimated $515K.
  • Roivant Sciences made up 0.05% of Winton Group's portfolio in Q2 2026, its #378 holding.
  • Winton Group first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
  • Winton Group's Roivant Sciences position peaked at $8.22M in Q3 2025.
  • 496 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.